CERS.NASDAQCerus CORP

SCHEDULE: ARK Investment Management and Catherine Wood Disclose 10.05% Stake in Cerus Corp

Sentiment:

Beneficial Ownership Report


ARK Investment Management LLC and Catherine D. Wood have jointly reported a beneficial ownership of 10.05% in Cerus Corp's Common Stock, totaling 19,207,604 shares.

Summary

  • ARK Investment Management LLC and Catherine D. Wood are the reporting persons for this beneficial ownership filing.
  • The filing pertains to Common Stock of CERUS CORP, identified by CUSIP 157085101.
  • The aggregate amount beneficially owned by the reporting persons is 19,207,604 shares.
  • This ownership represents 10.05% of the class of securities.
  • The filing is an Amendment No. 10 to Schedule 13G, with the event date being June 30, 2025.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
  • ARK Investment Management LLC holds sole voting power over 17,876,831 shares and sole dispositive power over 19,207,604 shares.
  • Catherine D. Wood holds shared voting power over 18,176,611 shares and shared dispositive power over 19,207,604 shares.
  • ARK Innovation ETF, a series of a Delaware statutory trust, is a client of ARK Investment Management LLC with an interest exceeding 5% in the reported securities.

Sentiment

Score: 7

Explanation: The filing indicates a substantial beneficial ownership by ARK Investment Management LLC and Catherine D. Wood, which can be interpreted as a positive signal of confidence in Cerus Corp by a prominent investment firm. However, it is purely an ownership disclosure and does not contain operational or financial performance data.

Positives

  • ARK Investment Management LLC and Catherine D. Wood, prominent investors known for their focus on disruptive innovation, hold a significant 10.05% beneficial ownership in Cerus Corp.
  • The stake is explicitly stated to be held in the ordinary course of business, indicating a passive investment intent rather than an activist or control-oriented purpose.

Negatives

  • No negative aspects related to Cerus Corp's operational performance, financial health, or strategic outlook are disclosed in this beneficial ownership filing.

Risks

  • No specific company risks or future challenges for Cerus Corp are detailed in this beneficial ownership filing, as its primary purpose is to disclose ownership percentages.

Future Outlook

This filing is a beneficial ownership report and does not contain any forward-looking statements or guidance regarding Cerus Corp's future outlook or financial performance.

Management Comments

  • The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This filing reflects a significant investment by a prominent asset manager, ARK Investment Management, known for its focus on disruptive innovation, in Cerus Corp, a company operating in the biomedical sector. Such a substantial stake by a well-known investor can signal confidence in the company's long-term prospects within the healthcare and blood safety industry.

Stakeholder Impact

  • Shareholders: The disclosure of a significant stake by a prominent investment firm like ARK Investment Management may increase visibility and potentially boost investor confidence in Cerus Corp.

Next Steps

  • No specific future actions, events, or milestones for Cerus Corp are mentioned in this ownership disclosure.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement.
07/30/2025Date of signing by ARK Investment Management LLC and Catherine D. Wood.

Keywords

CERUS CORP, ARK Investment Management, Catherine D. Wood, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Biomedical, Healthcare Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.